𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Corticostriatal covariance patterns of 6–[18F]fluoro–L–dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease

✍ Scribed by V. Kaasinen; R. P. Maguire; H.–P. Hundemer; K. L. Leenders

Publisher
Springer
Year
2005
Tongue
English
Weight
369 KB
Volume
253
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rate of progression in Parkinson's disea
Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study
✍ Elina Nurmi; Hanna M. Ruottinen; Jörgen Bergman; Merja Haaparanta; Olof Solin; P 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## Abstract The aim of this study was to investigate the rate of progression in Parkinson's disease (PD) with 6‐[^18^F]fluoro‐L‐dopa (FDOPA) positron emission tomography (PET). We investigated 21 patients with PD and eight healthy controls. Ten of the patients were de novo at the time of the first

A within-subject comparison of 6-[18F]fl
A within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson's disease
✍ Catherine L. Gallagher; Bradley T. Christian; James E. Holden; Onofre T. Dejesus 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

## Abstract Progression of Parkinson's disease symptoms is imperfectly correlated with positron emission tomography biomarkers for dopamine biosynthetic pathways. The radiopharmaceutical 6‐[^18^F]fluoro‐m‐tyrosine is not a substrate for catechol‐__O__‐methyltransferase and therefore has a more favo

6-[18F]fluoro-L-DOPA PET studies of the
6-[18F]fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys
✍ Doris J. Doudet; Grace L.Y. Chan; James E. Holden; Edith G. Mcgeer; Thomas A. Ai 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

This report describes a method to assess, in vivo, the turnover of dopamine (DA) and describes its application to the evaluation of DA function in normal monkeys and monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced lesions of the DA nigro-striatal pathway. Using positron emis

Striatal subregional 6-[18F]fluoro-L-dop
Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: A two-year follow-up study
✍ Anna Brück; Sargo Aalto; Elina Nurmi; Tero Vahlberg; Jörgen Bergman; Juha O. Rin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Abstract Thirty‐one drug‐naive patients with Parkinson's disease (PD) underwent 6‐[^18^F]fluoro‐L‐dopa (F‐dopa) positron emission tomography (PET) scan at the time of the diagnosis (baseline) and 2 years later in order to investigate F‐dopa uptake in striatal and extrastriatal regions during the